NBTX
Nanobiotix·NASDAQ
--
--(--)
--
--(--)
0.81 / 10
Underperform
The fundamental framework scores 0.8/10 - challenging quality. Supporting factors: Inventory turnover ratio and Gross profit margin (%), however risks emerge in Current assets turnover ratio and Fixed assets turnover ratio. Overall perspective: challenging.
Analysis Checks(3/5)
Inventory turnover ratio
Value37.99
Score2/3
Weight87.93%
1M Return-2.63%
Value37.99
Score2/3
Weight87.93%
1M Return-2.63%
Current assets turnover ratio
Value0.49
Score0/3
Weight63.39%
1M Return-1.88%
Value0.49
Score0/3
Weight63.39%
1M Return-1.88%
Net profit / Total profit (%)
Value100.09
Score2/3
Weight-48.98%
1M Return1.28%
Value100.09
Score2/3
Weight-48.98%
1M Return1.28%
Gross profit margin (%)
Value100.00
Score2/3
Weight-57.31%
1M Return1.47%
Value100.00
Score2/3
Weight-57.31%
1M Return1.47%
Fixed assets turnover ratio
Value4.79
Score1/3
Weight54.97%
1M Return-1.64%
Value4.79
Score1/3
Weight54.97%
1M Return-1.64%
Inventory turnover ratio
Value37.99
Score2/3
Weight87.93%
1M Return-2.63%
Value37.99
Score2/3
Weight87.93%
1M Return-2.63%
Gross profit margin (%)
Value100.00
Score2/3
Weight-57.31%
1M Return1.47%
Value100.00
Score2/3
Weight-57.31%
1M Return1.47%
Current assets turnover ratio
Value0.49
Score0/3
Weight63.39%
1M Return-1.88%
Value0.49
Score0/3
Weight63.39%
1M Return-1.88%
Fixed assets turnover ratio
Value4.79
Score1/3
Weight54.97%
1M Return-1.64%
Value4.79
Score1/3
Weight54.97%
1M Return-1.64%
Net profit / Total profit (%)
Value100.09
Score2/3
Weight-48.98%
1M Return1.28%
Value100.09
Score2/3
Weight-48.98%
1M Return1.28%
Is NBTX undervalued or overvalued?
- NBTX scores 0.81/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -382.75% net margin, -18.89 P/E ratio, -12.43 P/B ratio, and -38.52% earnings growth, these metrics solidify its Underperform investment rating.
